Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

MANÜ Telehealth vs Oak

Oak costs $1 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
MANÜ Telehealth logo

MANÜ Telehealth

6.9
★★★★☆3.5/5

Best for: semaglutide at $120/month, 44% below the typical price

Visit MANÜ Telehealth →
VS
Oak logo

Oak

7.8
★★★★☆3.9/5

Best for: semaglutide at $119/month, 37% below the typical price

Visit Oak →

If you are choosing between MANÜ Telehealth and Oak, the first difference is cost: Oak is $1 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Oak leads our six-part score, 7.8 to 6.9.

MANÜ Telehealth vs Oak price

Oak is the cheaper way in: $119 a month against $120 a month at MANÜ Telehealth. That is $1 less each month (1% lower), or about $12 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Oak ($119 a month vs $120 a month); tirzepatide is cheaper at MANÜ Telehealth ($150 a month vs $185 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format they match: each offers compounded injections.

Where each one treats patients

Neither MANÜ Telehealth nor Oak publishes the states it serves, so enter your state at the very start of each sign-up.

Pricing

MANÜ Telehealth

Standard titrationCompounded
$150/mo
tirzepatide
Standard titrationCompounded
$120/mo
semaglutide

Oak

Starting (flat across all dosages)Compounded
$119/mo
semaglutide

Semaglutide from $119/mo. A '$200 off' new-patient offer is advertised, but its terms and resulting price are not published. Other Oak pages show $133, $167 and $190; $119 is the headline price.

Starting (flat across all dosages)Compounded
$185/mo
tirzepatide

Tirzepatide from $185/mo, with 'One price · All dosages · No subscriptions.' A $200-off new-patient offer is advertised, but how it applies and the final price are not published before the intake questionnaire.

What each price covers

Both prices cover the medication itself and shipping.

MANÜ Telehealth's price also covers the clinician visit, which Oak does not claim.

Oak's price also covers coaching, which MANÜ Telehealth does not claim.

MANÜ Telehealth is silent on lab work and coaching.

Oak is silent on the clinician visit and lab work.

MANÜ Telehealth

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Oak

Covered by the monthly price

Medication

In the price

Clinician visits

Not stated

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Where each one scores higher

Overall, Oak scores 7.8 and MANÜ Telehealth 6.9 out of 10.

MANÜ Telehealth is stronger on value (8.7 vs 8.2) and support (7.0 vs 6.0).

Oak is stronger on user experience (8.0 vs 3.0) and trust & safety (6.5 vs 4.0).

Effectiveness and accessibility are within half a point.

How we score

MANÜ Telehealth

6.9/10

Overall

Oak

7.8/10

Value25%

8.7A
vs
B
8.2

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

4.0A
vs
B
6.5

Accessibility10%

5.0A
vs
B
5.0

Support10%

7.0A
vs
B
6.0

FDA warning letters

Neither MANÜ Telehealth nor Oak has an FDA warning letter on record with us.

Features & Coverage

FeatureMANÜ TelehealthOak
Starting Price$120/mo✓$119/mo
Features✓8 features4 features
States AvailableNot disclosedNot disclosed
Compounded✓ Yes✓ Yes
Brand Name——
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About MANÜ Telehealth

GLP-1s are advertised from about $4 to $5/day. MANÜ Telehealth sells compounded weight loss medication, injectable tirzepatide and semaglutide, with MIC Ultraburn and NAD+ injections offered as add-ons; US 503A pharmacies do the compounding. The US platform keeps the process 100% online, with monthly check-ins, board-certified physicians, free shipping and no insurance required. Which states are served can change; signup confirms it. Hormone optimization gets a mention but is not the primary focus. Compounded medications here are not FDA-evaluated.

Read our full MANÜ Telehealth review →

About Oak

Oak sells compounded semaglutide and tirzepatide through telehealth. Oak Longevity Holdings Corp. operates the business, and prescriptions are issued through NVP Medical Group, P.A.

Read our full Oak review →

Pros & Cons

MANÜ Telehealth

What we like

  • Tirzepatide costs $150 a month, 40% below the $250 median for compounded tirzepatide across the sellers we compare
  • Semaglutide costs $120 a month, 35% below the $185 median for compounded semaglutide across the sellers we compare
  • The monthly price includes the medication, clinician visits and shipping
  • We found no FDA warning letters issued to MANÜ Telehealth

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Oak

What we like

  • Semaglutide costs $119 a month, 36% below the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $185 a month, 26% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, shipping and coaching
  • We found no FDA warning letters issued to Oak

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Oak

Oak wins this one, 7.8 to 6.9, above all for semaglutide at $119/month, 37% below the typical price. It also costs $1 less each month than MANÜ Telehealth. MANÜ Telehealth fits better if semaglutide at $120/month, 44% below the typical price is your priority.

Choose MANÜ Telehealth if…

You want semaglutide at $120/month, 44% below the typical price and an opening price near $120 a month.

Choose Oak if…

You want semaglutide at $119/month, 37% below the typical price and an opening price near $119 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.4

Trimi Health

Knowing which pharmacy fills the vial: it names VialsRx

6.4

ShedRx

Oral orforglipron alongside the injectables

9.0

bmiMD

Starting below a standard dose, with microdose tiers

MANÜ Telehealth vs Oak: FAQ

Oak. It starts at $119 a month; MANÜ Telehealth starts at $120 a month, $1 more per month.
Yes, both sell semaglutide and tirzepatide.
MANÜ Telehealth does not publish where it ships; Oak does not publish where it ships. Confirm your state before paying.
Both include the medication itself and shipping. Only MANÜ Telehealth includes the clinician visit. Only Oak includes coaching.
MANÜ Telehealth has none. Oak has none.
Oak pays us a commission on sign-ups through our links; MANÜ Telehealth does not. Scores are computed the same way for both.

Or see the full category ranking.